Treating Colorectal Cancer in the Elderly

LISA SCHULMEISTER, MN, RN, ACNS-BC, FAAN
Tuesday, March 15, 2016
Talk about this article with nurses and others in the oncology community in the General Discussions Oncology Nursing News discussion group.
Treating older patients with metastatic cancer has become a topic of great interest. In addition to quality of life concerns, there are also other considerations, such as the cost of treatment, survival rates, and overall risks versus benefits.

Researchers from the University of Colorado Cancer Center and Colorado School of Public Health used Surveillance, Epidemiology, and End Results-Medicare data for patients diagnosed with metastatic colon (N=16,117) or rectal cancer (N=4008) between 2000 and 2009. They estimated the adjusted percentage of patients who received chemotherapy/targeted therapies and identified treatment costs.

The researchers found that there was a gain in overall survival of about 8 months in patients aged 65-74. However, this same benefit was not evident in patients older than age 75 despite the increase in the number of these patients being treated; the percentage of these older patients receiving three or more treatments increased from 2% to 53%.

During the 10-year study period, treatment costs increased 32% to reach an estimated $2.2 billion annually. However, median survival for these patients increased by only 1 month. Patients’ costs also increased; patients paid approximately $16,000 in out-of-pocket costs for care in 2009, compared with $11,000 in 2000. The researchers concluded that multi-agent regimens may not be of high value in terms of survival and costs for older patients with metastatic colorectal cancer.
 

Reference

Bradley CJ, Yabroff KR, Warren JL, et al. Trends in the treatment of metastatic colon and rectal cancer in elderly patients [published online ahead of print February 19, 2016]. Med Care.


Talk about this article with nurses and others in the oncology community in the General Discussions Oncology Nursing News discussion group.
Lisa Schulmeister, MN, RN, ACNS-BC, FAAN
 
Blog Info
Lisa Schulmeister, MN, RN, ACNS-BC, FAAN is an oncology nursing consultant and editor-in-chief of Oncology Nursing News.
Author Bio
Lisa Schulmeister, MN, RN, ACNS-BC, FAAN, is the Editor-in-Chief for OncLive Nursing. She is an oncology nursing consultant and adjunct assistant professor of nursing at Louisiana State Health Sciences Center in New Orleans, LA. She provides continuing nursing education to nurses across the Unites States, is active in several professional nursing organizations, and is intrigued by the many ways nurses use technology to communicate.
 
 
External Resources

MJH Associates
American Journal of Managed Care
Cure
MD Magazine
Pharmacy Times
Physicians' Education Resource
Specialty Pharmacy Times
TargetedOnc
OncNurse Resources

Blogs
Continuing Education
Discussions
Web Exclusives


About Us
Advertise
Advisory Board
Careers
Contact Us
Privacy Policy
Terms & Conditions
Intellisphere, LLC
2 Clarke Drive
Suite 100
Cranbury, NJ 08512
P: 609-716-7777
F: 609-716-4747

Copyright OncNursing 2006-2017
Intellisphere, LLC. All Rights Reserved.